Literature DB >> 33446095

Sarcopenia is associated with the presence of nonalcoholic fatty liver disease in Zhejiang Province, China: a cross-sectional observational study.

Yu-Ming Wang1,2, Ke-Fu Zhu3, Wen-Jing Zhou1,2, Qin Zhang1,2, Dan-Feng Deng1,2, Yi-Chen Yang1,2, Wen-Wen Lu1,2, Jia Xu2,4, Yun-Mei Yang5,6.   

Abstract

BACKGROUND: Currently, both non-alcoholic fatty liver disease (NAFLD) and sarcopenia have attracted extensive attention in public health. However, the relationship between NAFLD and sarcopenia remains unclear. This study aimed to clarify the sex-specific association between sarcopenia and NAFLD according to the Asian Working Group for Sarcopenia (AWGS).
METHODS: Dual-energy X-ray absorptiometry (DXA) and hepatic ultrasonography were measured in 578 participants (92 men and 486 women) during their annual health examinations. Multivariate logistic regression models were used to explore the association between NAFLD and sarcopenia with its two components.
RESULTS: A total of 154 participants (30 men and 124 women) had NAFLD. The prevalence of sarcopenia was higher among the participants with NAFLD than among those without NAFLD (men: 20.0% vs. 9.7%, P = 0.295, women: 15.3% vs. 8.0%, P = 0.019). Low muscle mass (LMM) was independently associated with NAFLD in both men and women (men: odds ratio [OR], 2.88; 95% confidence interval [CI] 1.52-5.46; women: OR, 2.08; 95% CI 1.63-2.67). However, low muscle strength (LMS) was independently associated with NAFLD only in male participants, with an OR of 1.15 (95% CI 1.02-1.28).
CONCLUSION: The occurrence of sarcopenia was associated with a higher risk of NAFLD, especially in men, as demonstrated by lower muscle mass and lower muscle strength.

Entities:  

Keywords:  Muscle mass; Muscle strength; Non-alcoholic fatty liver disease; Sarcopenia

Mesh:

Year:  2021        PMID: 33446095      PMCID: PMC7807816          DOI: 10.1186/s12877-020-01910-3

Source DB:  PubMed          Journal:  BMC Geriatr        ISSN: 1471-2318            Impact factor:   3.921


  29 in total

Review 1.  The Long Winding Road to Transplant: How Sarcopenia and Debility Impact Morbidity and Mortality on the Waitlist.

Authors:  Rahima A Bhanji; Elizabeth J Carey; Liu Yang; Kymberly D Watt
Journal:  Clin Gastroenterol Hepatol       Date:  2017-04-08       Impact factor: 11.382

Review 2.  Management of NAFLD: a stage-based approach.

Authors:  Mary E Rinella; Arun J Sanyal
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-02-24       Impact factor: 46.802

3.  Guidelines for the diagnosis and management of nonalcoholic fatty liver disease: update 2010: (published in Chinese on Chinese Journal of Hepatology 2010; 18:163-166).

Authors:  Jian Gao Fan; Ji Dong Jia; You Ming Li; Bing Yuan Wang; Lun Gen Lu; Jun Pin Shi; Lik Yuen Chan
Journal:  J Dig Dis       Date:  2011-02       Impact factor: 2.325

4.  Nonalcoholic steatohepatitis is strongly associated with sarcopenic obesity in patients with cirrhosis undergoing liver transplant evaluation.

Authors:  Sandra Carias; Ana Lia Castellanos; Valery Vilchez; Rashmi Nair; Anna Christina Dela Cruz; Jennifer Watkins; Terrence Barrett; Patel Trushar; Karyn Esser; Roberto Gedaly
Journal:  J Gastroenterol Hepatol       Date:  2016-03       Impact factor: 4.029

5.  Relationship Between Relative Skeletal Muscle Mass and Nonalcoholic Fatty Liver Disease: A 7-Year Longitudinal Study.

Authors:  Gyuri Kim; Seung-Eun Lee; You-Bin Lee; Ji Eun Jun; Jiyeon Ahn; Ji Cheol Bae; Sang-Man Jin; Kyu Yeon Hur; Jae Hwan Jee; Moon-Kyu Lee; Jae Hyeon Kim
Journal:  Hepatology       Date:  2018-10-14       Impact factor: 17.425

6.  Gender-specific risk factors for incident sarcopenia: 8-year follow-up of the English longitudinal study of ageing.

Authors:  Lin Yang; Lee Smith; Mark Hamer
Journal:  J Epidemiol Community Health       Date:  2018-10-27       Impact factor: 3.710

Review 7.  Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease.

Authors:  Chris Estes; Homie Razavi; Rohit Loomba; Zobair Younossi; Arun J Sanyal
Journal:  Hepatology       Date:  2017-12-01       Impact factor: 17.425

8.  Chronic hepatitis B, nonalcoholic steatohepatitis and physical fitness of military males: CHIEF study.

Authors:  Yu-Jung Chen; Kai-Wen Chen; Yu-Leung Shih; Fang-Ying Su; Yen-Po Lin; Fan-Chun Meng; Felicia Lin; Yun-Shun Yu; Chih-Lu Han; Chih-Hung Wang; Jia-Wei Lin; Tsai-Yuan Hsieh; Yi-Hwei Li; Gen-Min Lin
Journal:  World J Gastroenterol       Date:  2017-07-07       Impact factor: 5.742

9.  Components of metabolic syndrome increase the risk of mortality in nonalcoholic fatty liver disease (NAFLD).

Authors:  Pegah Golabi; Munkhzul Otgonsuren; Leyla de Avila; Mehmet Sayiner; Nila Rafiq; Zobair M Younossi
Journal:  Medicine (Baltimore)       Date:  2018-03       Impact factor: 1.889

Review 10.  Muscle loss and obesity: the health implications of sarcopenia and sarcopenic obesity.

Authors:  S Goya Wannamethee; Janice L Atkins
Journal:  Proc Nutr Soc       Date:  2015-04-27       Impact factor: 6.297

View more
  2 in total

Review 1.  Clinical practice advice on lifestyle modification in the management of nonalcoholic fatty liver disease in Japan: an expert review.

Authors:  Yoshihiro Kamada; Hirokazu Takahashi; Masahito Shimizu; Takumi Kawaguchi; Yoshio Sumida; Hideki Fujii; Yuya Seko; Shinya Fukunishi; Katsutoshi Tokushige; Atsushi Nakajima; Takeshi Okanoue
Journal:  J Gastroenterol       Date:  2021-10-31       Impact factor: 7.527

2.  Association Between Low Muscle Mass and Non-alcoholic Fatty Liver Disease Diagnosed Using Ultrasonography, Magnetic Resonance Imaging Derived Proton Density Fat Fraction, and Comprehensive NAFLD Score in Korea.

Authors:  Hun Ju Lee; Jae Seung Chang; Jhii Hyun Ahn; Moon Young Kim; Kyu-Sang Park; Yeon-Soon Ahn; Sang Baek Koh
Journal:  J Prev Med Public Health       Date:  2021-10-22
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.